Amisulpride prevents nausea and vomiting associated with highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled, dose-ranging trial - Herrstedt, Jørn; Jordan, Karin (Supportive care in cancer, 2019)
First online: 28 November 2018